Baby Jarro-Dophilus + FOS By Jarrow Formulas Overview & Drug Interactions

Check For Interactions With Baby Jarro-Dophilus + FOS

Supplement: Baby Jarro-Dophilus + FOS by Jarrow Formulas

Baby Jarro-Dophilus + FOS Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Baby Jarro-Dophilus + FOS by Jarrow Formulas

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Children less than 4 years of age
Minimum serving Sizes:
0.0625 tsp
Maximum serving Sizes:
0.25 tsp
Servings per container 71
UPC/BARCODE 790011030133

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Probiotic Bacteria
3000000000 Organism(s)
Blend (non-nutrient/non-botanical) --
B. breve M-16V
0 NP
Bifidobacterium breve
B. lactis BI-04
0 NP
Bifidobacterium animalis lactis
B. longum BB536
0 NP
Bifidobacterium longum
B. bifidum Bb-02
0 NP
Bifidobacterium bifidum
L. casei R0215
0 NP
Lactobacillus casei
L. rhamnosus Lr-32
0 NP
Lactobacillus rhamnosus
Galacto-oligosaccharides
600 mg
Galactooligosaccharides --
Inulin-FOS
200 mg
Blend (Dietary substance used by man to supplement the diet by increasing the total dietary intake) --

Other Ingredients:
Maltodextrin
Tapioca Starch
Tricalcium Phosphate
Vitamin C


Label Statments:


Suggested/Recommended/Usage/Directions
- USAGE: Up to age 4, mix 1/4 teaspoon per day in water, juice, lukewarm infant formula or food or as directed by your qualified healthcare professional. For newborns, mix into formula only 1/16 teaspoon per day for the first week. A small amount of powder may also be dabbed on mother’s wet nipple before breast feeding.
Precautions
- DO NOT feed powder directly to infants or children.
- Keep out of the reach of children.
- Contains: Dairy (casein) and soy (in trace amounts).
Brand IP Statement(s)
- Baby’s Jarro-Dophilus(R) contains superior, scientifically documented strains. Clinical studies have documented the benefits of B. breve M-16V and B. longum BB536 in infants and young children. GOS (GalactoOligoSaccharides) is similar to the oligosaccharides found in human milk. Both GOS and FOS (FructoOligoSaccharides) enhance the colonization of beneficial intestinal flora such as Bifidobacteria.
- Jarrow Formulas(R) puts the “PRO” in probiotics(R)
- (C) 2013 Jarrow FORMULAS(R)
General Statements
- Each gram (approximately 1/4 teaspoon) contains a minimum of 3 billion probiotic organisms.
- Lot #. Best Used Before:
- With Clinically Documented Strains
- 3 BILLION PER CAPSULE
- POWDER
- NOTE: Color of product naturally varies from white to tan.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Formula
- New With GOS
- Contains: Dairy (casein) and soy (in trace amounts).
FDA Statement of Identity
- PROBIOTIC SUPPLEMENT
Formulation
- No wheat, no gluten, no egg, no fish/shellfish, no peanuts/tree nuts.
Storage
- KEEP REFRIGERATED.
General
- 12512BAB PROD # 103013
Seals/Symbols
- GLUTEN FREE

Brand Information

See all products by this brand

Distributed Exclusively by
Name Jarrow Formulas Superior Nutrition and Formulation
Street Address P.O. Box 35994
City Los Angeles
State CA
ZipCode 90035-4317
Web Address www.Jarrow.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.